In Silico, In Vitro, and In Vivo Evaluation of Woodfordia Fruticosa for Cardio Protection against Doxorubicin‐Induced Cardiomyopathy
- 11 November 2025
- journal article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (1) , e02217
Abstract
This study aimed to evaluate the therapeutic potential of Woodfordia fruticosa , known for its cardioprotective properties, using in silico, in vitro, and in vivo methods. Fourier‐transform infrared spectroscopy (FTIR) and gas chromatography–mass spectrometry (GC–MS) analyses were used to identify and characterize the bioactive compounds in W. fruticosa . Molecular docking with dock score assessed the binding affinities of hecogenin, β‐sitosterol, and pulmatin. Antioxidant potential was evaluated using 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assays. In vivo experiments involved inducing cardiomyopathy in Wistar albino rats with doxorubicin (16 mg/kg, ip) and treating them with W. fruticosa flower extract at doses of 100, 200, and 400 mg/kg for 16 days. Molecular docking studies revealed that hecogenin, β‐sitosterol, and pulmatin exhibited strong binding affinities against human protein kinase ZAK, with Dock scores of −12.07, −11.42, and −11.04, respectively, surpassing the standard drug ramipril (−9.32). FTIR and GC–MS confirmed the presence of key phytoconstituents, including β‐sitosterol, hecogenin, ellagic acid, kaempferol, and 2‐hydroxy‐1,4‐naphthoquinone (Lawsone). In vitro antioxidant assays demonstrated significant free radical scavenging activity comparable to ascorbic acid. In vivo studies in Wistar albino rats showed that W. fruticosa flower extract significantly ( p < 0.001) improved electrocardiogram (ECG) parameters, and significantly ( p < 0.001) reduced cardiac biomarkers, including creatine kinase myocardial band (CK‐MB), lactate dehydrogenase (LDH), and cardiac troponin I, and mitigated histopathological damage in a dose‐dependent manner caused by doxorubicin. The 400 mg/kg dose exhibited the most pronounced cardioprotective effects, normalizing ECG patterns, decreasing myocardial injury, and reducing fibrosis. W. fruticosa flower extract exhibited significant cardioprotective potential via the human protein kinase ZAK pathway against doxorubicin‐induced cardiomyopathy through in silico, in vitro, and in vivo evaluations. These findings suggest W. fruticosa as a promising natural agent for cardiomyopathy management, warranting further studies to elucidate its mechanisms, optimize dosing, and validate long‐term safety and efficacy.Keywords
This publication has 64 references indexed in Scilit:
- Woodfordia fruticosa (L.) Kurz: in vitro biotechnological interventions and perspectivesApplied Microbiology and Biotechnology, 2023
- Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in ratsEnvironmental Science and Pollution Research, 2021
- Functional attributes of polyphenol-rich Woodfordia fruticosa extract: An active ingredient in traditional Indian medicine with nutraceutical potentialJournal of Herbal Medicine, 2021
- Bisoprolol and linagliptin ameliorated electrical and mechanical isometric myocardial contractions in doxorubicin-induced cardiomyopathy in ratsPharmacological Reports, 2019
- Pharmacological Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel PerspectivesEuropean Journal of Heart Failure, 2016
- ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activationMolecular and Cellular Biochemistry, 2015
- Effects of Histidine and N-Acetylcysteine on Doxorubicin-Induced Cardiomyopathy in RatsCardiovascular Toxicology, 2013
- Fourier Transform Infrared Spectroscopy for Molecular Analysis of Microbial Cells2012
- Evaluation of radical scavenging potential and total phenol content in Woodfordia fruticosa from different altitudesJournal of Plant Biochemistry and Biotechnology, 2011
- The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in ratEuropean Journal of Pharmacology, 2010